COVID-19 Records

Email

NIH Hid Public Comments Package, pp.99-100 · nih_public_comments:email:00103

Page text: p.99, p.100 · original PDF

Date
2022-01-14 09:22
Type
email · email
cc
Crystal Spruill, Scott Prince, David Lankford, Renate Myles, Lydia Polimeni, Amanda Fine, Haley Spencer
sender
Sarah J. Imhoff
to
Anna Kern
Topics
Media strategy and public messagingVaccines

This text appears inside a quoted reply chain — it is evidence that the message was circulating, not necessarily a new message.

f(OD)[ Lankford, nate (NIH/OD) [E] limeni, Lydia < < @palladianpartners.com> Subject: RE: PETA Lawsuit Update and Requests for Information Hi everyone, I have two additional follow-up questions from the DOJ: 1. Were the twitter posts on the 10/3/14 discussion on brain health linked below posted directly on NIH's Twitter account main page? Or was there a separate "chat" where these were posted? Plaintiffs want to know if anyone that went to the NIH's twitter account during that time would have seen those posts. 2. Are you aware of complaints we've received against other types of posts, unrelated to animal testing? E.g., posts concerning Dr. Fauci, or posts concerning vaccine misinformation? I know I've asked this before, but Plaintiffs specifically want to know if the complaints NIH receives are really focused on PETA, or if NIH received complaints about inflammatory posts on a variety of subjects. I think Plaintiffs want to make the argument that NIH is targeted animal rights posts over other inflammatory posts when they are equally inappropriate. Since Plaintiffs want this answer as part of our fact stipulation negotiations, I think we have to provide it. Thank you, Sarah J. Imhoff, JD, MHSA Senior Attorney Office of the General Counsel Public Health Division, NIH Branch (direct) @nih.gov This e-mail message is intended for the exclusive use of the recipient(s) named above. It may contain information that is protected, privileged, or confidential, and it should not be disseminated, distributed, or copied to persons not authorized to receive such information. If you are not the intended recipient, any dissemination, distribution, or copying is strictly prohibited. If you think you have received this e-mail message in error, please notify the sender immediately.